25 results
S-3
EX-4.1
CNSP
Cns Pharmaceuticals Inc
Shelf registration
9 May 24
5:28pm
S-3
EX-4.2
CNSP
Cns Pharmaceuticals Inc
Shelf registration
9 May 24
5:28pm
8-K
EX-4.2
CNSP
Cns Pharmaceuticals Inc
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.1
CNSP
Cns Pharmaceuticals Inc
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.3
CNSP
Cns Pharmaceuticals Inc
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-4.1
7lj83c8hq6ewgf
17 Oct 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-4.1
t50pguxd
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-4.3
i5sx3
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-4.2
r4mvd1b
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-4.1
b28ptqsmi79q2y7 5kg
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
8-K
EX-4.2
d0km8 qp1ad
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
S-3
EX-4.1
px47u3ar 5jxe6pzn
27 Jan 21
Shelf registration
4:02pm